AstraZeneca reaffirms Covishield vaccine safety amid rare side effect concerns
The company's assurance comes days after it accepted that its Covid vaccines Covishield and Vaxzevria can, in very rare cases, cause Thrombosis with Thrombocytopenia Syndrome (TTS) - characterized by blood clots and low platelet counts.